Aldeyra Therapeutics Inc. (ALDX)
NASDAQ: ALDX
· Real-Time Price · USD
5.33
0.03 (0.57%)
At close: Aug 15, 2025, 3:47 PM
Aldeyra Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 244.53K | 244.53K | 244.53K | 392.62K | 392.62K | 392.62K | 392.62K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 308.44K | 307.79K | 307.51K | 251.72K | 253.73K | 256.44K | 262.78K | 196.31K | 196.62K | 196.29K | 192.06K | 253.33K | 256.38K | 192.36K | 197.49K | 136.22K | 67.86K | 67.86K |
Gross Profit | -63.92K | -63.27K | -62.99K | -251.72K | -253.73K | -256.44K | -262.78K | -196.31K | -196.62K | -196.29K | -192.06K | -253.33K | -256.38K | -259.06K | -264.18K | -202.91K | -134.56K | -67.86K |
Operating Income | -10,168.8B | -61.15M | -60.12M | -49.64M | -43.05M | -35.38M | -42.79M | -50.39M | -55.63M | -63M | -62.68M | -64.39M | -65.04M | -61.87M | -56.22M | -52.1M | -45.05M | -37.61M |
Interest Income | 4.6M | 5.36M | 6.19M | 6.81M | 7.21M | 7.45M | 7.32M | 6.72M | 5.47M | 3.93M | 2.35M | 1.16M | 567.7K | 262.98K | 185.36K | 127.93K | 73.84K | 105.89K |
Pretax Income | -9,767.4B | -57.7M | -55.85M | -44.8M | -37.87M | -30.01M | -37.54M | -45.69M | -52.06M | -60.85M | -62.02M | -64.88M | -66.12M | -63.27M | -57.78M | -53.79M | -46.87M | -39.45M |
Net Income | -9,767.4B | -57.7M | -55.85M | -44.8M | -37.87M | -30.01M | -36.85M | -44.99M | -51.13M | -59.99M | -62.16M | -65.02M | -66.49M | -63.58M | -57.78M | -53.31M | -46.39M | -38.98M |
Selling & General & Admin | 1,663.5B | 11.56M | 11.83M | 11.62M | 10.51M | 10.91M | 13.27M | 16.27M | 16.93M | 16.69M | 15.37M | 13.2M | 12.5M | 12.43M | 11.28M | 11.23M | 10.94M | 10.09M |
Research & Development | 8,505.3B | 49.47M | 48.23M | 37.89M | 32.41M | 24.41M | 29.46M | 34.12M | 38.7M | 46.31M | 47.31M | 51.19M | 52.54M | 49.44M | 44.94M | 39.12M | 32.36M | 25.77M |
Other Expenses | -10,168.7B | 61.46K | -492 | 66.29K | 65.29K | 65.29K | 65.78K | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 53.25M | 61.09M | 60.06M | 49.58M | 42.99M | 35.38M | 42.79M | 50.39M | 55.63M | 63M | 62.68M | 64.39M | 65.04M | 61.87M | 56.22M | 50.35M | 43.3M | 35.86M |
Interest Expense | 1.9M | 1.91M | 1.93M | 1.97M | 2.03M | 2.08M | 2.07M | 2.02M | 1.9M | 1.78M | 1.69M | 1.65M | 1.64M | 1.67M | 1.74M | 1.82M | 1.89M | 1.95M |
Selling & Marketing Expenses | n/a | -61.63K | -61.63K | -128.1K | -128.1K | -66.47K | -66.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 53.31M | 61.15M | 60.12M | 49.64M | 43.05M | 35.38M | 42.79M | 50.39M | 55.63M | 63M | 62.68M | 64.39M | 65.04M | 61.87M | 56.22M | 50.35M | 43.3M | 35.86M |
Income Tax Expense | 3.00 | 3.00 | 3.00 | n/a | n/a | n/a | -696K | -696K | -927K | -860.98K | 139.6K | 139.6K | 429.91K | 403.56K | 122.73K | -356.27K | -410.36K | -378.31K |
Shares Outstanding (Basic) | 60.05M | 59.89M | 59.48M | 59.53M | 59.41M | 59.41M | 59.2M | 58.99M | 58.79M | 58.79M | 58.56M | 58.46M | 58.3M | 58.3M | 58.02M | 58.02M | 54.28M | 45.63M |
Shares Outstanding (Diluted) | 60.05M | 59.89M | 59.48M | 59.53M | 59.41M | 59.41M | 59.2M | 58.99M | 58.79M | 58.79M | 58.56M | 58.46M | 58.3M | 58.3M | 58.02M | 58.02M | 54.28M | 45.63M |
EPS (Basic) | -0.85 | -0.97 | -0.94 | -0.75 | -0.64 | -0.51 | -0.62 | -0.76 | -0.86 | -1.02 | -1.06 | -1.11 | -1.14 | -1.11 | -1.07 | -1.05 | -1.01 | -0.98 |
EPS (Diluted) | -0.85 | -0.97 | -0.94 | -0.75 | -0.64 | -0.51 | -0.62 | -0.76 | -0.86 | -1.02 | -1.06 | -1.11 | -1.14 | -1.11 | -1.07 | -1.05 | -1.01 | -0.98 |
EBITDA | -10,168.8B | -55.54M | -53.68M | -42.57M | -35.59M | -27.67M | -35.21M | -43.41M | -49.9M | -58.81M | -60.07M | -62.98M | -64.22M | -61.35M | -55.77M | -51.77M | -44.77M | -37.29M |
EBIT | -48.71M | -55.79M | -53.93M | -42.83M | -35.84M | -27.93M | -35.47M | -43.67M | -50.16M | -59.07M | -60.33M | -63.23M | -64.48M | -61.61M | -56.03M | -51.97M | -44.98M | -37.51M |
Depreciation & Amortization | 250.55K | 249.9K | 249.62K | 251.72K | 253.73K | 256.44K | 262.78K | 262.95K | 263.26K | 262.94K | 258.71K | 253.33K | 256.38K | 259.06K | 264.18K | 40.91K | 45.68K | 51.63K |